InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Discover the detailed record of transactions filed by CHALMERS DEREK T, Chief Executive Officer. Insider active across 1 companies, notably Cara Therapeutics, Inc.. Cumulatively, 6 reports have been logged. Total volume traded: €726k. The latest transaction was filed on 7 September 2021 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations6 total
€261,23920,000 shares@ €13.061972.0% of flow
Common Stock
SEC:0001209191-21-055304·
€261,23920,000 shares@ €13.061936.0% of flow
Common Stock
SEC:0001209191-21-055304:0·
€101,5938,440 shares@ €12.037128.0% of flow
Common Stock
SEC:0001209191-21-054300·
€101,5938,440 shares@ €12.037114.0% of flow
Common Stock
SEC:0001209191-21-054300:0·
017,334 shares0
Common Stock
SEC:0001209191-21-053534·
017,334 shares0
Common Stock
SEC:0001209191-21-053534:0·
6 of 6 declarations
About CHALMERS DEREK T
Derek T. Chalmers is the President and CEO of Cara Therapeutics, Inc. He oversees the company's operations and is responsible for implementing the business strategy. Derek plays a crucial role in leading the company and making strategic decisions. His leadership is essential for ensuring Cara Therapeutics' growth and success.
